PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Klotz, L.V. ; Lindner, M. ; Eichhorn, M.E.* ; Grützner, U.* ; Koch, I.* ; Winter, H.* ; Kauke, T.* ; Duell, T.* ; Hatz, R.

Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma.

J. Thorac. Dis. 11, 1963-1972 (2019)
Verlagsversion DOI PMC
Open Access Gold
Background: Malignant pleural mesothelioma (MPM) is an aggressive malignancy with few long-term survivors. Despite the dismal prognosis, hyperthermic intrathoracic chemoperfusion (HITHOC) was shown to improve survival in a selective group of patients. We analyzed the influence of HITHOC following pleurectomy and decortication on postoperative morbidity and overall survival for patients suffering from localized mesothelioma. Methods: From 2009 until 2013, 71 patients with localized pleural mesothelioma underwent pleurectomy and decortication followed by HITHOC with cisplatin and doxorubicin. We analyzed postoperative morbidity, age, overall survival and influence of macroscopic resection on survival. Results: Median patient age was 70 years (range, 65-73 years). Patients having the sarcomatoid subtype of mesothelioma showed a poor median survival of 9.2 months. In contrast, patients having the epithelioid subtype had a median survival of 17.9 months. Patients following macroscopic complete resection had a significantly better survival with 28.2 months compared to 13.1 months in patients with incomplete resection of the mesothelioma (P<0.0001). HITHOC was performed in all patients after tumor resection using cisplatin and doxorubicin. Conclusions: Taken together, HITHOC following pleurectomy and decortication is supposed to be a safe therapeutic option for selected patients with localized epithelial pleural mesothelioma.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.027
0.969
8
10
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Pleural Mesothelioma ; Chemoperfusion, Decortication ; Cisplatin ; Hyperthermic Intrathoracic Chemoperfusion (hithoc); Cytoreductive Surgery; Pleurectomy-decortication; Extended Pleurectomy; Chemotherapy; Survival; Management; Diagnosis; Classification; Metaanalysis; Guidelines
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 2077-6624
e-ISSN 2072-1439
Zeitschrift Journal of thoracic disease
Quellenangaben Band: 11, Heft: 5, Seiten: 1963-1972 Artikelnummer: , Supplement: ,
Verlag Pioneer Bioscience Publ.
Verlagsort Hong Kong
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Lung Health and Immunity (LHI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Lung Research
PSP-Element(e) G-501600-001
G-501600-003
DOI 10.21037/jtd.2019.04.93
WOS ID WOS:000469979100030
Scopus ID 85067114078
PubMed ID 31285889
Erfassungsdatum 2019-06-24
[➜Korrektur melden]